--AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study-February 2024-www.financetom.com

--AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study

May 13, 2024 9:52 AM

12:38 PM EDT, 05/13/2024 (MT Newswires) --

Price: 77.30, Change: +0.12, Percent Change: +0.16

Previous page： Starbucks China attracts bids at up to $10 billion valuation, CNBC reports Next page：

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Starbucks China attracts bids at up to $10 billion valuation, CNBC reports

Jul 8, 2025

(Reuters) -Starbucks' ( SBUX ) China business has attracted offers for a potential stake sale, valuing the coffee chain unit at up to $10 billion, CNBC reported on Wednesday, citing people familiar with the matter. Asia-based private equity firms Centurium Capital and Hillhouse Capital as well as U.S. peers Carlyle Group ( CG ) and KKR & Co ( KKR...

Jul 8, 2025

...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Jul 8, 2025

...